No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
Filings
Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.
| Company | Type | Value | Reported | Company | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC.General Counsel | Open-market sell | $256,46475,364 shares | Sep 15, 2026 | ROCKET PHARMACEUTICALS, INC.General Counsel | $256,464 | Open-market sell | 75,364 | Sep 15, 2026 |
| ROCKET PHARMACEUTICALS, INC.General Counsel | Open-market sell | $2,133631 shares | Aug 20, 2026 | ROCKET PHARMACEUTICALS, INC.General Counsel | $2,133 | Open-market sell | 631 | Aug 20, 2026 |
| ROCKET PHARMACEUTICALS, INC.General Counsel | Open-market sell | $11,8103,493 shares | Aug 17, 2026 | ROCKET PHARMACEUTICALS, INC.General Counsel | $11,810 | Open-market sell | 3,493 | Aug 17, 2026 |